Company intelligence / Profile preview

Cevaxin

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Cevaxin has conducted over forty clinical studies involving more than twenty-one thousand participants across all phases of vaccine development. The center is recognized for its high-quality data generation and contribution to global health research, particularly in vaccine-preventable diseases. It has played a key role in pivotal studies on polio eradication and emerging infectious diseases such as dengue and COVID‑19.

Therapeutic areas: Infectious Diseases
Modalities: Vaccine
Industry: Contract Research Organization

Partnerships

Collaborates with national/international sponsors including the Bill & Melinda Gates Foundation, Panama Ministry of Health, Children’s Hospital Panama CityWorks with >15 sponsors overall.

Beyond the preview

Go deeper on Cevaxin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cevaxin.

Explore the full profile